Acute Management of Cyanotic (Hypercyanotic) Spells in Tetralogy of Fallot
Immediately place the infant in knee-chest position, administer oxygen, give morphine sulfate 0.1-0.2 mg/kg IV/IM/SC, and provide a 10-20 mL/kg normal saline bolus—these first-line interventions address the pathophysiology by increasing systemic vascular resistance and reducing right-to-left shunting. 1
Pathophysiology Understanding
Hypercyanotic spells occur from acute infundibular spasm causing dramatic reduction in pulmonary blood flow, increased right-to-left shunting through the VSD, and precipitous drop in arterial oxygen saturation. 2 These episodes are medical emergencies that can cause neurological damage or death if not promptly treated. 2
First-Line Interventions (Implement Immediately and Simultaneously)
Positioning
- Place infant in knee-chest position to increase systemic vascular resistance (SVR), decrease right-to-left shunting, and improve pulmonary blood flow. 1, 3
Oxygen Administration
- Provide 100% oxygen to maximize oxygen delivery, though saturation improvement may be limited due to persistent right-to-left shunting. 1, 3
Pharmacologic Sedation
- Administer morphine sulfate 0.1-0.2 mg/kg IV/IM/SC to reduce infundibular spasm, provide sedation, decrease respiratory drive, and reduce oxygen consumption. 1, 4
- Alternative: Intranasal fentanyl has been successfully used when IV access is difficult, with symptom resolution within 10 minutes. 5
- Alternative: Intranasal midazolam can be effective for initial calming before IV access is established, particularly in crying, hyperpneic infants where IV placement is challenging. 6
Volume Resuscitation
- Give IV fluid bolus 10-20 mL/kg normal saline to increase preload, cardiac output, and improve pulmonary blood flow. 1
Second-Line Interventions (If First-Line Measures Fail)
Vasopressor Therapy
- Administer phenylephrine 5-10 μg/kg IV bolus (followed by infusion if needed) to increase SVR, force more blood through pulmonary circulation, and reduce right-to-left shunting. 1, 3
- Alternative: Epinephrine 10 μg/kg if phenylephrine is not readily available. 7
- Alternative: Terlipressin (a potent vasoconstrictor) has been reported as effective rescue therapy when alpha-agonists are unavailable, producing significant and sustained increases in arterial saturation. 2
Anesthetic Agents
- Consider ketamine 1-2 mg/kg IV (or 4-5 mg/kg IM) for sedation and treatment of infundibular spasm, as it maintains SVR while providing analgesia and sedation. 1, 4
Emergency Interventions (For Refractory Spells)
Airway Management
- Prepare for intubation and controlled ventilation to reduce oxygen consumption, allow controlled sedation, and potentially increase pulmonary blood flow. 1
- Administer IV lidocaine 1-1.5 mg/kg within 5 minutes before extubation to reduce risk of laryngospasm. 4
Rescue Measures for Complete Failure
- Emergent cardiac catheterization for thrombus removal if shunt thrombosis suspected. 7
- Emergent sternotomy for thrombectomy to milk shunt of thrombosis. 7
- ECMO stabilization if above maneuvers unsuccessful. 7
Critical Monitoring During Episode
- Continuous pulse oximetry and cardiac monitoring are essential. 1, 3
- Blood pressure monitoring to assess response to vasopressors. 1
- Consider cerebral oxygen saturation monitoring for neurologic protection assessment. 1, 3
Common Pitfalls to Avoid
- Avoid decreasing SVR through vasodilators or excessive anesthetic depth, as this worsens right-to-left shunting. 3
- Avoid factors that increase pulmonary vascular resistance including hypoxia, hypercarbia, acidosis, and hypothermia. 4
- Do not delay IV access attempts but recognize that intranasal medications (fentanyl or midazolam) provide effective alternatives when venous access is difficult in a crying, cyanotic infant. 5, 6
Definitive Management
Surgical repair is the ultimate solution for preventing future episodes and should be expedited, as hypercyanotic spells represent an indication for urgent surgical intervention. 7, 1 Primary complete intracardiac repair in infancy has hospital survival >98% and 30-year survival >90%. 3